Federal Circuit backs Broad Institute in CRISPR patent dispute
In a closely-watched CRISPR patent case, the Federal Circuit says the PTAB did not err in concluding that Broad Institute’s claims would not have been obvious over the University of California’s claims
The Federal Circuit has ruled that the Patent Trial and
Appeal Board (PTAB) did not err in concluding that the Broad
Institute’s CRISPR patent claims would not have
been obvious over the University of California (UC) claims,
affirming the Board...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.